Comparison of HER2 Expression in Primary Tumor and Disseminated Tumor Cells in the Bone Marrow of Breast Cancer Patients

Publisher： Karger

E-ISSN： 1423-0232|90|4|232-238

ISSN： 0030-2414

Source： Oncology, Vol.90, Iss.4, 2016-03, pp. : 232-238

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Significance of apoptotic and non‐apoptotic disseminated tumor cells in the bone marrow of patients with clinically localized prostate cancer

By  

THE PROSTATE, Vol. 75, Iss. 6, 2015-05 ,pp. : 637-645

John Wiley & Sons Inc

Access to resources Recommend Favorite

Redefining micrometastasis in prostate cancer - a comparison of circulating prostate cells, bone marrow disseminated tumor cells and micrometastasis: Implications in determining local or systemic treatment for biochemical failure after radical prostatectomy

By                  

International Journal of Molecular Medicine, Vol. 30, Iss. 4, 2012-01 ,pp. : 896-904

Spandidos Publications

Access to resources Recommend Favorite

Circulating and Disseminated Tumor Cells in the Clinical Management of Breast Cancer Patients: Unanswered Questions

By  

Oncology, Vol. 76, Iss. 6, 2009-04 ,pp. : 375-386

Karger

Access to resources Recommend Favorite

Comparison of intratumoral heterogeneity of HER2 expression between primary tumor and multiple organ metastases in gastric cancer: Clinicopathological study of three autopsy cases and one resected case

By  

PATHOLOGY INTERNATIONAL, Vol. 65, Iss. 6, 2015-06 ,pp. : 309-317

John Wiley & Sons Inc

Access to resources Recommend Favorite

Expression of insulin‐like growth factor‐1 receptor in circulating tumor cells of patients with breast cancer is associated with patient outcomes

By  

Molecular Oncology, Vol. 12, Iss. 1, 2018-01 ,pp. : 21-32

John Wiley & Sons Inc

Access to resources Recommend Favorite